Product Images Topiramate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Topiramate NDC 47335-712 by Sun Pharmaceutical Industries, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
100mg - 100mg
200mg - 200mg
Each brown-colored, im-coated circular fim-coated tablet contains 200 mg topiramate, USP. The tablet is imprinted with *S* and 712. It is recommended to store the medication between 20°C to 25°C (68°F to 77°F) and excursions permitted to 15°C to 30°C (59°F to 86°F) in a tight container, protected from moisture. Topiramate Tablets, USP 200 mg is used as per the usual dosage whose details can be found in the accompanying product literature. The pharmacist must dispense the medication guide available at their website to each patient. The medication is distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, and manufactured by Sun Pharmaceutical industries Limited — Survey No. 259/15, Dacra-396 191, (UT of D & NH), India. The NDC number is 47335-712-86.*
25mg - 25mg
This is a prescription medication with the NDC 47335-707-86 for Topiramate Tablets, USP in the strength of 25 mg. The pharmacist is advised to dispense it with a medication guide for each patient. The label contains 60 tablets, and the drug is only available by prescription. There is a barcode for scanning and a reference code at the bottom. *
50mg - 50mg
Topiramate Tablets, USP is a medication that comes in a tablet form with a strength of 50mg. It is Rx only and should be dispensed with a medication guide to each patient. The National Drug Code (NDC) for this medication is 47335-710-86, and it comes in a bottle of 60 tablets manufactured by SUN. Some additional codes are mentioned, but their meaning is not clear.*
chemical-structure - chemical structure
figure-1jpg - figure 1
This text shows the cumulative rates for time to first seizure for two different doses of Topiramate (50 mg/day and 400 mg/day) over a period of 500 days. The graph shows the probability of experiencing a seizure at a given time during the observation period. The results suggest that the higher dose of Topiramate is more effective in preventing seizures, as the cumulative rate is lower than the lower dose. The p-value of 0.0002 indicates that the difference in effectiveness between the two doses is statistically significant.*
figure-2 - figure 2
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.